[(1-methyl-1H-imidazol-2-yl)thio]acetic acid hydrochloride, 95.0%, 10g

6-Bromo-3-chloro-2-methoxypyridine, 97%, 100mg

Hydrochloric acid, ROTI®Volum 0.5 mol/l - 0.5 N, ampoule, 1 piece, plastic packaging.

2,6-Difluoro-3-nitrobenzaldehyde, 98.0%, 1g

4-bromo-5-methyl-3-isoxazolol, 95.0%, 1g

Allylsulfanyl-acetic acid, 95.0%, 5g

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(4-CYANOPHENYL)BUTANOIC ACID, 95%, 5g

4-bromo-N-[(2-methoxyphenyl)methyl]benzenesulfonamide, 95%, 100mg

2-Bromo-4-methoxyphenylacetic Acid>98.0%(GC)(T)1g

GC capillary column ROTI®Cap-624, 30 m, 0.32 mm, 1.80 µm, 1 Piece(s)

5-(aminomethyl)-2-adamantanol hydrochloride hydrate, 95.0%, 250mg

5-(3-(4-(4-Chlorophenyl)piperidin-1-yl)propyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one, 97.0%, 50mg

1,6,10-Dodecatriene, 7,11-dimethyl-3-methylene-, (6E)-, 95%, 5g